GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (LTS:0A7L) » Definitions » Forward PE Ratio

iRhythm Technologies (LTS:0A7L) Forward PE Ratio : 0.00 (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is iRhythm Technologies Forward PE Ratio?

iRhythm Technologies's Forward PE Ratio for today is 0.00.

iRhythm Technologies's PE Ratio without NRI for today is 0.00.

iRhythm Technologies's PE Ratio for today is 0.00.


iRhythm Technologies Forward PE Ratio Historical Data

The historical data trend for iRhythm Technologies's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Forward PE Ratio Chart

iRhythm Technologies Annual Data
Trend
Forward PE Ratio

iRhythm Technologies Quarterly Data
Forward PE Ratio

Competitive Comparison of iRhythm Technologies's Forward PE Ratio

For the Medical Devices subindustry, iRhythm Technologies's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRhythm Technologies's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where iRhythm Technologies's Forward PE Ratio falls into.



iRhythm Technologies Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


iRhythm Technologies  (LTS:0A7L) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


iRhythm Technologies Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


iRhythm Technologies (LTS:0A7L) Business Description

Traded in Other Exchanges
Address
699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

iRhythm Technologies (LTS:0A7L) Headlines

No Headlines